trending Market Intelligence /marketintelligence/en/news-insights/trending/QPn1jEHcy4EEJKf71PYxaA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Teladoc closes common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Teladoc closes common stock offering

Teladoc Inc. closed its public offering of 9,487,500 common shares at $16.75 per share to raise net proceeds of $124.1 million.

The company offered 7,887,500 shares and 1.6 million shares were offered by certain stockholders. The underwriters fully exercised their option to buy an additional 1,237,500 common shares.

Net proceeds of the primary portion of the offering will be used for working capital and general corporate purposes, including to expand its current business through acquisitions of, or investments in, other businesses, products or technologies.

Teladoc did not receive any proceeds from common shares sold by the selling stockholders.

J.P. Morgan and Piper Jaffray & Co. acted as joint book-running managers for the offering and as representatives of the underwriters. Wells Fargo Securities and William Blair also acted as joint book-running managers for the offering. SunTrust Robinson Humphrey and Oppenheimer & Co. acted as co-managers for the offering.